Search

everythinglearnresearchcommunity

for

Search:↓

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

PCOS is a complex condition that can lead to serious health issues, but early diagnosis and treatment can reduce these risks.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Some women with PCOS have rare genetic variants linked to the condition.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.